Literature DB >> 18362513

Oxygen delivery enhancers: past, present, and future.

P Borrione1, A Mastrone, R A Salvo, A Spaccamiglio, L Grasso, A Angeli.   

Abstract

In endurance sport the delivery of oxygen to muscles plays a critical role. Indeed, muscle performance declines during prolonged and intense activity as a consequence of the shift from the aerobic to the anaerobic metabolism with an increase of lactate. To enhance the aerobic capacity 2 alternatives may be used: increasing either the transport or the delivery of oxygen. In this setting, blood doping is the practice of illicitly using a drug or blood product to improve athletic performance. Based on this definition, blood doping techniques may include: 1) blood transfusion (autologous or omologous); 2) erythropoiesis-stimulating substances [recombinant human erythropoietin (alpha, beta, omega), darbepoietin-alpha, continuous erythropoiesis receptor activator, hematide]; 3) blood substitutes (hemoglobin-based oxygen carriers, perfluorocarbon emulsions); 4) allosteric modulators of hemoglobin (RSR-13 and RSR-4); 5) gene doping (human erythropoietin gene transfection); 6) gene regulation (hypoxia-inducible transcription factors pathway). In the present overview we will briefly describe the above-mentioned techniques with the aim of underlining potential hematological alternatives to gene doping for increasing aerobic capacity in sport.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362513     DOI: 10.1007/BF03345588

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  38 in total

1.  FDA sounds alert on anemia drugs.

Authors:  Mike Mitka
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

2.  Mapping of the active site of recombinant human erythropoietin.

Authors:  S Elliott; T Lorenzini; D Chang; J Barzilay; E Delorme
Journal:  Blood       Date:  1997-01-15       Impact factor: 22.113

Review 3.  Sites of erythropoietin production.

Authors:  P H Maxwell; D J Ferguson; L G Nicholls; J P Iredale; C W Pugh; M H Johnson; P J Ratcliffe
Journal:  Kidney Int       Date:  1997-02       Impact factor: 10.612

4.  Expression cloning of the murine erythropoietin receptor.

Authors:  A D D'Andrea; H F Lodish; G G Wong
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

5.  Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure.

Authors:  L C Clark; F Gollan
Journal:  Science       Date:  1966-06-24       Impact factor: 47.728

6.  The effect of common hematologic abnormalities on the ability of blood models to detect erythropoietin abuse by athletes.

Authors:  Robin Parisotto; Michael J Ashenden; Christopher J Gore; Ken Sharpe; Will Hopkins; Allan G Hahn
Journal:  Haematologica       Date:  2003-08       Impact factor: 9.941

7.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.

Authors:  B A Witthuhn; F W Quelle; O Silvennoinen; T Yi; B Tang; O Miura; J N Ihle
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

8.  Detection of recombinant human erythropoietin in urine by isoelectric focusing.

Authors:  Andreas Breidbach; Don H Catlin; Gary A Green; Inna Tregub; Henry Truong; Jeffrey Gorzek
Journal:  Clin Chem       Date:  2003-06       Impact factor: 8.327

9.  In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction.

Authors:  J Fandrey; H F Bunn
Journal:  Blood       Date:  1993-02-01       Impact factor: 22.113

10.  A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.

Authors:  J Malyszko; J S Malyszko; J Borawski; A Rydzewski; M Kalinowski; A Azzadin; M Mysliwiec; W Buczko
Journal:  Thromb Res       Date:  1995-01-15       Impact factor: 3.944

View more
  1 in total

1.  Phenoxyaromatic Acid Analogues as Novel Radiotherapy Sensitizers: Design, Synthesis and Biological Evaluation.

Authors:  Hongquan Zhang; Chunxi Wen; Bingting Li; Xinlin Yan; Yangrong Xu; Jialin Guo; Shi Hou; Jiajia Chang; Song Li; Junhai Xiao
Journal:  Molecules       Date:  2022-04-09       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.